Literature DB >> 22471286

Characteristics of alloreactive T cells measured before renal transplantation.

P J E J van de Berg1, S L Yong, S D Koch, N Lardy, K A M I van Donselaar-van der Pant, S Florquin, F J Bemelman, R A W van Lier, I J M ten Berge.   

Abstract

Several assays to measure pre-existing allospecific T cell immunity in renal transplant candidates have been developed in the past years. In 46 patients, we used flow cytometry-based mixed lymphocyte culture to measure the precursor frequency and phenotype of alloreactive T cells before renal transplantation, using donor-specific or third-party cells for allostimulation. Allostimulation induced up-regulation of co-stimulatory molecules, chemokine receptors relevant for migration of T cells into the graft and effector proteins. Recipients prone for acute rejection had a higher precursor frequency of alloreactive CD8(+) T cells and a lower percentage of interleukin (IL)-7Rα expressing alloreactive CD8(+) T cells than non-rejectors. These data point to quantitative and qualitative differences between T cells of patients who will experience acute cellular rejection episodes from those who will not.
© 2011 The Authors;Clinical and Experimental Immunology © 2011 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22471286      PMCID: PMC3390526          DOI: 10.1111/j.1365-2249.2011.04551.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  38 in total

Review 1.  Regulatory T cells in transplantation tolerance.

Authors:  Kathryn J Wood; Shimon Sakaguchi
Journal:  Nat Rev Immunol       Date:  2003-03       Impact factor: 53.106

Review 2.  Chemokines and their receptors as markers of allograft rejection and targets for immunosuppression.

Authors:  Wayne W Hancock; Liqing Wang; Qunrui Ye; Rongxiang Han; Iris Lee
Journal:  Curr Opin Immunol       Date:  2003-10       Impact factor: 7.486

Review 3.  Cytokine control of memory T-cell development and survival.

Authors:  Kimberly S Schluns; Leo Lefrançois
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

4.  Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced.

Authors:  N M van Besouw; B J van der Mast; P de Kuiper; P J Smak Gregoor; L M Vaessen; J N IJzermans; T van Gelder; W Weimar
Journal:  Transplantation       Date:  2000-07-15       Impact factor: 4.939

5.  Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.

Authors:  B Sis; M Mengel; M Haas; R B Colvin; P F Halloran; L C Racusen; K Solez; W M Baldwin; E R Bracamonte; V Broecker; F Cosio; A J Demetris; C Drachenberg; G Einecke; J Gloor; D Glotz; E Kraus; C Legendre; H Liapis; R B Mannon; B J Nankivell; V Nickeleit; J C Papadimitriou; P Randhawa; H Regele; K Renaudin; E R Rodriguez; D Seron; S Seshan; M Suthanthiran; B A Wasowska; A Zachary; A Zeevi
Journal:  Am J Transplant       Date:  2010-01-29       Impact factor: 8.086

6.  Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine.

Authors:  Ravi Raju Tatapudi; Thangamani Muthukumar; Darshana Dadhania; Ruchuang Ding; Baogui Li; Vijay K Sharma; Elizabeth Lozada-Pastorio; Nagashree Seetharamu; Choli Hartono; David Serur; Surya V Seshan; Sandip Kapur; Wayne W Hancock; Manikkam Suthanthiran
Journal:  Kidney Int       Date:  2004-06       Impact factor: 10.612

7.  Differential immunogenicity of paternal HLA Class I antigens in pregnant women.

Authors:  Marlies K A Dankers; Dave L Roelen; Nelleke Korfage; Peter de Lange; Marian Witvliet; Lodewijk Sandkuijl; Ilias I N Doxiadis; Frans H J Claas
Journal:  Hum Immunol       Date:  2003-06       Impact factor: 2.850

8.  Evolution of the enzyme-linked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool.

Authors:  Britta S Gebauer; Donald E Hricik; Aymen Atallah; Kathryn Bryan; Jocelyn Riley; Magdalena Tary-Lehmann; Neil S Greenspan; Cora Dejelo; Bernhard O Boehm; Bernhard J Hering; Peter S Heeger
Journal:  Am J Transplant       Date:  2002-10       Impact factor: 8.086

9.  Alloreactivity in renal transplant recipients with and without chronic allograft nephropathy.

Authors:  Emilio D Poggio; Michael Clemente; Jocelyn Riley; Meagan Roddy; Neil S Greenspan; Cora Dejelo; Nader Najafian; Mohamed H Sayegh; Donald E Hricik; Peter S Heeger
Journal:  J Am Soc Nephrol       Date:  2004-07       Impact factor: 10.121

10.  Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.

Authors:  Susan M Kaech; Joyce T Tan; E John Wherry; Bogumila T Konieczny; Charles D Surh; Rafi Ahmed
Journal:  Nat Immunol       Date:  2003-11-16       Impact factor: 25.606

View more
  3 in total

1.  Terminally Differentiated Effector Memory CD8+ T Cells Identify Kidney Transplant Recipients at High Risk of Graft Failure.

Authors:  Lola Jacquemont; Gaëlle Tilly; Michelle Yap; Tra-My Doan-Ngoc; Richard Danger; Pierrick Guérif; Florent Delbos; Bernard Martinet; Magali Giral; Yohann Foucher; Sophie Brouard; Nicolas Degauque
Journal:  J Am Soc Nephrol       Date:  2020-03-12       Impact factor: 10.121

2.  Expansion of highly differentiated cytotoxic terminally differentiated effector memory CD8+ T cells in a subset of clinically stable kidney transplant recipients: a potential marker for late graft dysfunction.

Authors:  Michelle Yap; Françoise Boeffard; Emmanuel Clave; Annaick Pallier; Richard Danger; Magali Giral; Jacques Dantal; Yohann Foucher; Cécile Guillot-Gueguen; Antoine Toubert; Jean-Paul Soulillou; Sophie Brouard; Nicolas Degauque
Journal:  J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 10.121

3.  T Cells With Activated STAT4 Drive the High-Risk Rejection State to Renal Allograft Failure After Kidney Transplantation.

Authors:  Yihan Chen; Bao Zhang; Tianliang Liu; Xiaoping Chen; Yaning Wang; Hongbo Zhang
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.